Success Metrics

Clinical Success Rate

80.0%

Based on 4 completed trials

Completion Rate

80%(4/5)

Active Trials

2(22%)

Results Posted

50%(2 trials)

Terminated

1(11%)

Phase Distribution

Ph phase_1

33%

Ph phase_4

22%

Ph early_phase_1

11%

Ph phase_2

11%

Ph phase_3

22%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution9 total trials

Early Phase 1First-in-human

1(11.1%)

Phase 1Safety & dosage

3(33.3%)

Phase 2Efficacy & side effects

1(11.1%)

Phase 3Large-scale testing

2(22.2%)

Phase 4Post-market surveillance

2(22.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

4 of 6 finished

Non-Completion Rate

33.3%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(4)

Terminated(2)

Other(1)

Detailed Status

Completed4

Active, not recruiting1

unknown1

Terminated1

Withdrawn1

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

80.0%

Most Advanced

Phase 4

Trials by Phase

Early Phase 11 (11.1%)

Phase 13 (33.3%)

Phase 21 (11.1%)

Phase 32 (22.2%)

Phase 42 (22.2%)

Trials by Status

active_not_recruiting111%

unknown111%

terminated111%

withdrawn111%

recruiting111%

completed444%

Recent Activity

2 active trials

Showing 5 of 9

active_not_recruitingphase_4

Opioid, HIV and Immune System

NCT04304768

withdrawnphase_1

A Study to Evaluate the Intratumoral Influenza Vaccine Administration in Patients With Breast Cancer

NCT06229392

recruitingearly_phase_1

Intradermal Influenza Vaccination

NCT06067555

terminatedphase_4

Comparison of Recombinant Influenza Vaccine Versus Standard Egg-Based Inactivated Influenza Vaccine in Adults 18-64 Years

NCT05514002

completedphase_1

Effects of Aging on Primary and Secondary Vaccine Responses

NCT03312699

View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials

NCT04304768Phase 4

Opioid, HIV and Immune System

Active Not Recruiting

NCT06229392Phase 1

A Study to Evaluate the Intratumoral Influenza Vaccine Administration in Patients With Breast Cancer

Withdrawn

NCT06067555Early Phase 1

Intradermal Influenza Vaccination

Recruiting

NCT05514002Phase 4

Comparison of Recombinant Influenza Vaccine Versus Standard Egg-Based Inactivated Influenza Vaccine in Adults 18-64 Years

Terminated

NCT03312699Phase 1

Effects of Aging on Primary and Secondary Vaccine Responses

Completed

NCT04120194Phase 3

Phase 3 Pivotal Trial of NanoFlu™ in Older Adults

Completed

NCT03926416Phase 1

Safety Study of Live Attenuated Influenza Vaccine, CodaVax

Completed

NCT02242643Phase 3

Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine (GSK2282512A) Compared to Fluzone® Quadrivalent in Children 6 to 35 Months of Age

Completed

NCT02434276Phase 2

Study of the Immunogenicity and Safety of a Quadrivalent Influenza Vaccine (VAX2012Q) in Adults 18-64 Years

Unknown

All 9 trials loaded

Drug Details

Intervention Type: BIOLOGICAL
Total Trials: 9